Researchers

no image

INOUE Hiroaki
Assistant Professor A in Medical School
Faculty Department of Medicine
Researchmap https://researchmap.jp/inouehiroaki

Education and Career

Education

  • - 2008/03 , Kindai University, Faculty of Medicine,

Academic & Professional Experience

  • - Today , Kindai University Faculty of Medicine 助教

Research Activities

Research Areas

  • Life sciences, Hematology and oncology

Research Interests

HIV感染症, 悪性リンパ腫

Published Papers

  1. Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma.
    Takahiro Haeno; Shinya Rai; Yoshiaki Miyake; Maiko Inoue; Ko Fujimoto; Aki Fujii; Yoshio Iwata; Shuji Minamoto; Takahide Taniguchi; Hiroaki Kakutani; Hiroaki Inoue; Takahiro Kumode; Kentaro Serizawa; Yasuhiro Taniguchi; Chikara Hirase; Yasuyoshi Morita; Hirokazu Tanaka; Yoichi Tatsumi; Takashi Ashida; Itaru Matsumura
    Journal of clinical and experimental hematopathology : JCEH  63  (2)  , 99-107, 28, Jun. 2023 
  2. CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence
    Kentaro Serizawa; Hirokazu Tanaka; Takeshi Ueda; Ayano Fukui; Hiroaki Kakutani; Takahide Taniguchi; Hiroaki Inoue; Takahiro Kumode; Yasuhiro Taniguchi; Shinya Rai; Chikara Hirase; Yasuyoshi Morita; J. Luis Espinoza; Yoichi Tatsumi; Takashi Ashida; Itaru Matsumura
    International Journal of Hematology  115  (3)  , 336-349, Mar. 2022 
  3. Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.
    Shinya Rai; Hiroaki Inoue; Kazuko Sakai; Hitoshi Hanamoto; Mitsuhiro Matsuda; Yasuhiro Maeda; Takahiro Haeno; Yosaku Watatani; Takahiro Kumode; Kentaro Serizawa; Yasuhiro Taniguchi; Chikara Hirase; J Luis Espinoza; Yasuyoshi Morita; Hirokazu Tanaka; Takashi Ashida; Yoichi Tatsumi; Kazuto Nishio; Itaru Matsumura
    Cancer science  113  (2)  , 660-673, Feb. 2022 

MORE

Conference Activities & Talks

  1. COVID-19罹患後に1型糖尿病を発症した2例 , 葉山僚哉; 山下貴史; 村上冴子; 杉本浩嗣; 岩田吉生; 井上宏昭; 花岡郁子 , 日本内分泌学会雑誌 , 2024
  2. フォンウィルブランド因子存在下で血腫を来した本態性血小板血症の1例 , 杉本浩嗣; 岩田吉生; 井上宏昭 , 臨床血液 , 2023
  3. Outcomes of allo-SCT for patients in non-remission especially with chemoresistance , 谷口康博; 芦田隆司; 森田泰慶; 平瀬主税; 頼晋也; 中山聖子; 芹澤憲太郎; 口分田貴裕; 井上宏昭; 岩田吉男; 谷口貴英; 源周治; 角谷宏明; 藤本昂; 小森舞子; 波江野高大; 三宅義昭; 辰巳陽一; 田中宏和; 松村到 , 日本造血細胞移植学会総会プログラム・抄録集 , 2020

MORE

MISC

  1. Pembrolizumab as a salvage therapy for patients with refractory or relapse primary mediastinal large B-cell lymphoma. , 井上宏昭; 頼晋也 , 月刊血液内科 , 81 , 2 , 2020
  2. 脳静脈洞血栓症を合併し、開頭減圧術・術後エクリズマブ投与が有効であったPNHの一例(Post-operative treatment with eculizumab for PNH presenting as cerebral venous sinus thrombosis) , 岩田 吉生; 森田 泰慶; 辻 潔; 頼 晋也; 田崎 貴之; 井上 宏昭; 谷口 康博; 藤本 昂; 田中 宏和; 芦田 隆司; 加藤 天美; 松村 到 , 臨床血液 , 59 , 9 , 1765 , 1765 , Sep. 2018
  3. 末梢血幹細胞採取前のCD34細胞数測定の有用性 , 山田枝里佳; 斉藤花往里; 藤本昂; 角谷宏明; 岩田吉生; 谷口貴英; 源周治; 大山泰世; 口分田貴裕; 井上宏昭; 芹澤憲太郎; 谷口康博; 頼晋也; 平瀬主税; 森田泰慶; 田中宏和; 岡野意浩; 坂田尚己; 芦田隆司; 松村到 , 日本アフェレシス学会雑誌 , 37 , Supplement , 2018

MORE